Delivery Order SPE2DB22D3004-SPE2DB25FRK07
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,068.11 by the Defense Logistics Agency (DLA) on July 11, 2025, for the supply of Nexletol 180 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 14, 2025, and represents a child award under AmerisourceBergen's larger indefinite delivery contract with DLA. The pharmaceutical distributor will fulfill...
- The Defense Logistics Agency awarded a $2,172.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Nexletol 180 mg tablets (30-count units) with an ultimate completion date of September 24, 2025. This non-set-aside award was issued on September 23, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,162.98 to AmerisourceBergen Drug Corp for NEXLETOL 180 mg tablets (30-count units) on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. NEXLETOL is a non-statin, non-ezetimibe medication used to manage cholesterol levels in patients with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Nexletol 180 mg tablets in quantities of 30 units. This competitive, firm fixed-price delivery order carries a ceiling value of $1,269.01 and has an ultimate completion date of August 19, 2025. The contract involves no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Nexletol 180 mg tablets (30-count units) on September 2, 2025, with a ceiling value of $2,667.56 and an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,476.15 firm fixed-price delivery order is for the supply of NEXLETOL 180 MG TABLET, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 18, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is a $3,453.94 delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The delivery order is for the supply of NEXLETOL 180 MG TABLET, a specialty pharmaceutical product, with a completion date of February 8, 2024. Amerisourcebergen Drug Corp has an indefinite delivery contract (IDC) with DLA Troop...
- This is a $3,793.11 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEXLETOL 180 MG TABLET, a medication, with a completion date of May 27, 2025. The contract is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a $1,988.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Nexletol 180 mg tablets in quantities of 30 units. This is a non-set-aside delivery order with an ultimate completion date of September 11, 2025, and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,736.73 award is for the supply of NEXLETOL 180 MG Tablets and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRK07Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,208.72 for NEXLETOL 180 mg tablets (30-count units) with an ultimate completion date of July 11, 2025. This is a firm fixed-price, non-set-aside contract performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999 ceiling value through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains extensive federal contracting relationships primarily with the Defense Logistics Agency and its Medical Supply Chain. The company's IDC vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling the delivery of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs and the Defense Health Agency worldwide. This delivery order for NEXLETOL represents one of numerous competitive awards the vendor fulfills under this prime contract vehicle, demonstrating its capability to meet federal pharmaceutical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 7/10/25 |